Table 1 The correlation between the expression levels of PlncRNA-1 and clinicopathological features of BC patients.

From: Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis

Characteristics

Total

PlncRNA-1

p Value

Low

High

Gender

M

24

13

11

0.596

F

4

1

3

Age (year)

<65

12

8

4

0.252

≥65

16

6

10

Recurrent status

Primary

18

10

8

0.693

Recurrence

10

4

6

Preoperative treatment

None

15

8

7

1.000

Treatment

13

6

7

Surgical approach

Partial cystectomy

3

1

2

1.000

Radical cystectomy

25

13

12

Pathological grade

Low

7

5

2

0.379

High

18

7

11

NA

3

2

1

Size (cm)

<4 cm

13

7

6

1.000

≥4 cm

15

7

8

No. of tumors

Single

3

0

3

0.222

Multiple

25

14

11

Tumor invasion

NMIBC

10

8

2

0.049

MIBC

18

6

12

T stage

T1–T2

22

14

8

0.002

T3–T4

6

0

6

N stage

N0

25

14

11

0.222

N1

3

0

3

M stage

M0

27

14

13

1.000

M1

1

0

1